Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Trebananib |
Trade Name | |
Synonyms | AMG 386|AMG386 |
Drug Descriptions |
Trebananib (AMG 386) inhibits angiogenesis through binding to the angiopoietins Ang1 and Ang2, thereby preventing interaction with their receptors (PMID: 32154928). |
DrugClasses | |
CAS Registry Number | 894356-79-7 |
NCIT ID | C91711 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + Trebananib | Bevacizumab Trebananib | 0 | 2 |
Paclitaxel + Trastuzumab + Trebananib | Paclitaxel Trastuzumab Trebananib | 0 | 0 |
Paclitaxel + Trebananib | Paclitaxel Trebananib | 0 | 0 |
Pazopanib + Trebananib | Pazopanib Trebananib | 0 | 1 |
Pegylated liposomal doxorubicin + Trebananib | Pegylated liposomal doxorubicin Trebananib | 0 | 0 |
Pembrolizumab + Trebananib | Pembrolizumab Trebananib | 0 | 1 |
Sorafenib + Trebananib | Sorafenib Trebananib | 0 | 1 |
Sunitinib + Trebananib | Sunitinib Trebananib | 0 | 1 |
Trastuzumab + Trebananib | Trastuzumab Trebananib | 0 | 0 |
Trebananib | Trebananib | 0 | 4 |